16 results
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 •
., 4 mg/kg on days ... dose of 20–60 mg/kg ... ., 4 mg/kg on days ... Leishmaniasis #Prevention #Treatment ... opportunistic #infections #HIVAIDS
IDSA Treatment Recommendations for Cryptococcal Meningoencephalitis in Human Immunodeficiency Virus Infected Individuals
Induction therapy:
 • AmBd (0.7–1.0
IDSA Treatment Recommendations ... AmBd (0.7–1.0 mg/kg ... or ABLC (5 mg/kg ... Meningoencephalitis #IDSA #Treatment ... #cryptococcus #HIVAIDS
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
duration same as for treatment ... Disease Note: Treatment ... Nifurtimox 8–10 mg/kg ... IDSA #Prevention #Treatment ... opportunistic #infections #HIVAIDS
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
amphotericin B, 3 to 5 mg/kg ... IDSA #Prevention #Treatment ... opportunistic #infections #HIVAIDS
Causes of Lactate Elevation, Lactic Acidosis - Differential Diagnosis

The most common causes of hyperlactatemia are usually:
by excretion (e.g ... its metabolism (e.g ... / hypoxemia -> focus ... perfusion - shock->treatments ... before beginning treatment
IDSA Recommendations for Treating Herpes Simplex Virus (HSV) Infections in HIV-AIDS
Treating Orolabial Lesions (Duration: 5–10 days)
acyclovir 5 mg/kg ... • Continue treatment ... IDSA #Prevention #Treatment ... opportunistic #infections #HIVAIDS
IDSA Recommendations for Preventing and Treating Cryptococcosis in HIV-AIDS
Treatment for cryptococcosis consists of 3 phases: induction,
Cryptococcosis in HIV-AIDS Treatment ... flucytosine 25 mg/kg ... flucytosine 25 mg/kg ... IDSA #Prevention #Treatment ... opportunistic #infections #HIVAIDS
IDSA Recommendations for Treating Coccidiodomycosis in HIV-AIDS
Treating Mild Infections (Such As Focal Pneumonia or asymptomatic patients
amphotericin B 3–5 mg/kg ... deoxycholate 0.7–1.0 mg/kg ... IDSA #Prevention #Treatment ... opportunistic #infections #HIVAIDS
IDSA Recommendations for Treating Cytomegalovirus Infections in HIV-AIDS
Preventing CMV Disease:
 • CMV end-organ disease is best
other factors (e.g ... ability to adhere to treatment ... whenever feasible, treatment ... effective for treatment ... opportunistic #infections #HIVAIDS
IDSA Recommendations for Treating Bartonella Infections in HIV-AIDS
Preferred Therapy
For Bacillary Angiomatosis, Peliosis Hepatis, Bacteremia, and Osteomyelitis:
gentamicin 1 mg/kg ... course of primary treatment ... IDSA #Prevention #Treatment ... opportunistic #infections #HIVAIDS